Germany Respiratory Device Market 2021-2027: Industry Analysis, Trends, Growth, Opportunities, and Forecast

Germany respiratory device market was valued at around $1.1 billion in 2018 and is estimated to grow at a CAGR of around 6.5% during the forecast period. The rising prevalence of chronic respiratory diseases, increasing geriatric population, and technological advancement are the major factors that augmenting the growth of respiratory device market in the country. Further, well-developed healthcare infrastructure and the presence of key market players in the country are fueling the growth of the country’s market. Market players operating in the country are adopting various strategies which are providing the needful thrust to the market growth.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/germany-respiratory-device-market

Germany respiratory device market is segmented on the basis of product and end-user. The respiratory product segment is further sub-segmented into therapeutic devices, diagnosis and monitoring devices, and consumables and accessories. The therapeutic devices segment is estimated to dominate the market and is also anticipated to grow at the fastest growth rate over the forecast period. The high cost of therapeutics device and significant demand for continuous positive airway pressure (CPAP) devices and masks, ventilator, oxygen concentrator, and oxygen hoods contribute majorly to the segmental growth of the market for therapeutic devices. Based on end-user, the market is analyzed into hospitals and clinics, and home care.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/germany-respiratory-device-market

Additionally, the market is characterized by the presence of several players that are providing respiratory devices within and outside the region. Some of the key players of the market include Bayer AG, ResMed Corp., Chiesi Farmaceutici S.P.A., GlaxoSmithKline PLC, Novartis AG, Boehringer Ingelheim International GmbH, and Drägerwerk AG., and others. Ingelheim-based Boehringer Ingelheim International GmbH collaborated with Weill Cornell Medicine in February 2017. The aim of the collaboration is to find new treatment approaches for chronic pulmonary diseases. The three-year collaboration aimed to develop novel treatments that could stop and decrease the progression of COPD. Additionally, in June 2017, the company announced a research collaboration with Harvard Stem Cell Institute, the alliance was formed to discover new treatment for idiopathic pulmonary fibrosis.

Market Segmentation
Germany Respiratory Device Market by Product
• Therapeutic Devices
• Diagnostic and Monitoring Devices
• Consumable and Accessories

Germany Respiratory Device Market by End-User
• Homecare
• Hospitals and Clinics

Company Profiles
• 3M Co.
• Acorda Therapeutics, Inc.
• Adamis Pharmaceuticals Corp.
• Adherium Ltd.
• Air Liquide S.A.
• AstraZeneca PLC
• Bayer AG
• Bespak
• Boehringer Ingelheim International GmbH
• Chiesi Farmaceutici S.P.A.
• Gilbert Technologies B.V.
• GlaxoSmithKline PLC
• H&T Presspart Manufacturing Ltd.
• Hamilton Medical AG
• Koninklijke Philips N.V.
• Medtronic PLC
• Novartis AG
• PMD Device Solutions Ltd.
• ResMed Corp.
• Savara, Inc.
• Teicos Pharma Ltd.
• Teva Pharmaceuticals Industries Ltd.
• Vitalograph Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/germany-respiratory-device-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.